Graham Capital Management’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-48,945
Closed -$1.77M 1363
2023
Q1
$1.77M Buy
48,945
+12,364
+34% +$434K 0.05% 293
2022
Q4
$1.45M Buy
+36,581
New +$1.52M 0.04% 402
2022
Q3
Sell
-26,608
Closed -$1.17M 1368
2022
Q2
$1.17M Buy
26,608
+20,031
+305% +$1.1M 0.05% 390
2022
Q1
$475K Buy
6,577
+2,456
+60% +$177K 0.02% 570
2021
Q4
$334K Buy
+4,121
New +$413K 0.01% 282

Other funds holding NVRO

Graham Capital Management's NVRO Position: Q2 2023 in Review

Graham Capital Management sold out of NEVRO CORP. (NVRO) in Q2 2023, closing a stake of 48,945 shares — an estimated $1.77M sold.

Graham Capital Management first reported a position in NVRO in Q4 2021 and held it in 5 quarters. The position peaked at $1.77M in Q1 2023. 155 funds tracked by Wall St. Rank hold NVRO as of Q2 2023.

  • Graham Capital Management reported no remaining NEVRO CORP. position as of Q2 2023 after selling out during the quarter.
  • Graham Capital Management sold 48,945 NEVRO CORP. shares in Q2 2023, an estimated $1.77M.
  • Graham Capital Management first reported a position in NEVRO CORP. in Q4 2021 and held it in 5 quarters.
  • Graham Capital Management's NEVRO CORP. position peaked at $1.77M in Q1 2023.
  • 155 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2023.

Based on Graham Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.